From: Diastolic function is a strong predictor of mortality in patients with chronic kidney disease
 | Number (%) |
---|---|
Mean age (year) | 65.6 ± 14.0 |
Male gender | 88 (57.5%) |
Medical history | |
Hypertension | 127 (85%) |
Diabetes | 69 (46%) |
 Oral hypoglycaemics | 25 (17%) |
 Insulin | 34 (23%) |
Heart failure | 20 (13%) |
Stroke | 23 (15%) |
Hyperlipidaemia | 90 (60%) |
Current smoker | 15 (10%) |
Atrial fibrillation | 10 (6.5%) |
AMI | 30 (20%) |
PCI | 25 (16%) |
CABG | 17 (11%) |
Patients on dialysis | 56 (37%) |
 Haemodialysis | 45 (29%) |
 Peritoneal dialysis | 13 (8%) |
Aetiology of kidney disease: | |
 Diabetes | 48 (31%) |
 Glomerulonephritis | 39 (25%) |
 Vascular | 13 (8%) |
 Hypertension | 10 (7%) |
 Vesicoureteric reflux | 9 (6%) |
 Congenital | 6 (4%) |
 Other | 28 (18%) |
Medications | |
 ACEI/ARB | 86 (56%) |
 Diuretic | 58 (38%) |
 Beta blocker | 64 (42%) |
 Statin | 92 (60%) |
 Calcium antagonist | 60 (39%) |
 Aspirin | 42 (27%) |
 EPO | 65 (42%) |